Banff 2016 Global Assessment and Quantitative Scoring for T Cell-Mediated Liver Transplant Rejection are Interchangeable

Table 3

Biopsy characteristics and histopathological outcome of the cohort.

Number of transplant recipients who underwent at least 1 biopsy in 12 months post-transplant	60 (37%)
Total number of biopsies	90
Biopsies/patient	Number of patients
1	41 (69%)
2	13 (21%)
3	3 (4.9%)
4	1 (1.6%)
5	2 (3.3%)
Time between LT and biopsy procedure
Days	Number of biopsies
1–90	54 (60%)
91–180	16 (18%)
181–365	20 (22%)
Histopathological outcome of biopsies	Number of biopsies
T cell-mediated rejection (TCMR)	64 (71.1%)
Nonspecific changes	8 (8.9%)
Preservation-reperfusion injury	4 (4.4%)
Cholestatic hepatitis	4 (4.4%)
Chronic rejection	3 (3.3%)
Hepatitis C virus	3 (3.3%)
Other^∗	4 (4.4%)

^∗Steatosis, submassive necrosis, insufficient tissue, suboptimal biopsy.